[go: up one dir, main page]

DK0725644T3 - Anvendelse af budesonid til fremstilling af et lægemiddel til behandling af tilstande, som beror på en reduceret enterisk v - Google Patents

Anvendelse af budesonid til fremstilling af et lægemiddel til behandling af tilstande, som beror på en reduceret enterisk v

Info

Publication number
DK0725644T3
DK0725644T3 DK94928390T DK94928390T DK0725644T3 DK 0725644 T3 DK0725644 T3 DK 0725644T3 DK 94928390 T DK94928390 T DK 94928390T DK 94928390 T DK94928390 T DK 94928390T DK 0725644 T3 DK0725644 T3 DK 0725644T3
Authority
DK
Denmark
Prior art keywords
budesonide
reduced
enteric
medicament
manufacture
Prior art date
Application number
DK94928390T
Other languages
English (en)
Inventor
Karl-Wilhelm Ecker
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6503342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0725644(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Application granted granted Critical
Publication of DK0725644T3 publication Critical patent/DK0725644T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94928390T 1993-11-24 1994-09-22 Anvendelse af budesonid til fremstilling af et lægemiddel til behandling af tilstande, som beror på en reduceret enterisk v DK0725644T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4340057A DE4340057A1 (de) 1993-11-24 1993-11-24 Budesonid-Arzneimittel zur Verbesserung der enteralen Flüssigkeitsresorption, insbesondere nach postoperativen Zuständen
PCT/EP1994/003165 WO1995014474A1 (de) 1993-11-24 1994-09-22 Budesonid-arzneimittel zur verbesserung der enteralen flüssigkeitsresorption, insbesondere nach postoperativen zuständen

Publications (1)

Publication Number Publication Date
DK0725644T3 true DK0725644T3 (da) 1999-02-08

Family

ID=6503342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928390T DK0725644T3 (da) 1993-11-24 1994-09-22 Anvendelse af budesonid til fremstilling af et lægemiddel til behandling af tilstande, som beror på en reduceret enterisk v

Country Status (7)

Country Link
EP (1) EP0725644B1 (da)
AT (1) ATE169220T1 (da)
DE (2) DE4340057A1 (da)
DK (1) DK0725644T3 (da)
ES (1) ES2120068T3 (da)
GR (1) GR3027725T3 (da)
WO (1) WO1995014474A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
PT835098E (pt) 1995-06-27 2002-12-31 Boehringer Ingelheim Pharma Nova composicao farmaceutica estavel para a producao de aerossois sem gas propulsante
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
EP3613414A1 (de) * 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016881A1 (en) * 1990-05-04 1991-11-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Colonic drug delivery system

Also Published As

Publication number Publication date
WO1995014474A1 (de) 1995-06-01
EP0725644B1 (de) 1998-08-05
DE4340057A1 (de) 1995-06-01
GR3027725T3 (en) 1998-11-30
EP0725644A1 (de) 1996-08-14
DE59406625D1 (de) 1998-09-10
ATE169220T1 (de) 1998-08-15
ES2120068T3 (es) 1998-10-16

Similar Documents

Publication Publication Date Title
EP4566608A3 (en) Therapeutic compounds for hiv virus infection
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
ES2051641B1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
ATE337786T1 (de) Verwendung von taurolidine oder taurultam zur behandlung und prävention von infektionen in medizinischen freisetzungssystemen
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
LV12719A (lv) Benzoxazinones as inhibitors of hiv reverse transcriptase
NO20063667L (no) Anvendelse av et anti-mikrotubulimiddel for fremstilling av en farmasoytisk blanding for behandling eller forhindring av kirurgiske adhesjoner
MX9308025A (es) Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene.
ATE245444T1 (de) Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen
DK0725644T3 (da) Anvendelse af budesonid til fremstilling af et lægemiddel til behandling af tilstande, som beror på en reduceret enterisk v
DE69924146D1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
DK0578477T3 (da) Behandling af inflammatorisk tarmsygdom
BR0016163A (pt) Tratamento de infecções virais que usa levovirin(r)
EE9700165A (et) Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
IS4555A (is) Notkun köfnunarefnisoxíð gjafa eða köfnunarefnisoxíð lata til að tempra leghálsvíkkun og þenslu
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
WO2001010454A3 (en) Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection
WO2005072091A3 (en) Methods for inhibiting hiv and other viral infections by modulating ceramide metabolism
UA42693C2 (uk) Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
DK1143976T3 (da) Beta-D-2', 3'-didehydro-2', 3'-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
AU2396900A (en) Treatment and prevention of hiv and other viral infections
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )